Crinetics Pharmaceuticals, Inc.
CRNX
35 insider filings · Latest: Sep 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Jul 7 8:30 PM | Coelho Rogerio VivaldiDirector | Sale | 3,000 | $40.00 | $120.0K | 19,225(D) | View → |
| Jul 2, 2026 | Jul 2 8:31 PM | JEFF KNIGHT | Proposed Sale | 47,420 | $38.68 | $1.8M | — | View → |
| Jul 2, 2026 | Jul 2 8:29 PM | ROGERIO VIVALDI COELHO | Proposed Sale | 6,000 | $38.68 | $232.1K | — | View → |
| Jun 17, 2026 | Jun 18 9:23 PM | Stephanie OkeyDirector | Sale | 6,900 | $35.67 | $246.1K | 6,400(D) | View → |
| Jun 17, 2026 | Jun 17 8:27 PM | STEPHANIE OKEY | Proposed Sale | 6,900 | $35.00 | $241.5K | — | View → |
| May 4, 2026 | May 4 8:26 PM | JEFF KNIGHT | Proposed Sale | 9,485 | $39.02 | $370.1K | — | View → |
| Apr 14, 2026 | Apr 14 8:37 PM | JEFF KNIGHT | Proposed Sale | 20,900 | $38.66 | $808.0K | — | View → |
| Apr 13, 2026 | Apr 13 8:36 PM | JEFF KNIGHT | Proposed Sale | 4,434 | $39.44 | $174.9K | — | View → |
| Apr 8, 2026 | Apr 10 8:33 PM | Jeff E. KnightChief Dev. & Operating Officer | Sale | 85,163 | $40.10 | $3.4M | 105,289(D) | View → |
| Apr 8, 2026 | Apr 8 8:49 PM | JEFF KNIGHT | Proposed Sale | 85,163 | $38.41 | $3.3M | — | View → |
| Mar 16, 2026 | Mar 18 9:13 PM | Jeff E. KnightChief Operating Officer | Sale | 9,911 | $37.37 | $370.4K | 112,018(D) | View → |
| Mar 16, 2026 | Mar 18 9:11 PM | Stephen F. BetzChief Scientific Officer | Sale | 10,612 | $37.37 | $396.6K | 137,101(D) | View → |
| Mar 16, 2026 | Mar 18 9:05 PM | Struthers Richard ScottDirector, President & CEO | Sale | 21,981 | $37.37 | $821.5K | 404,778(D) | View → |
| Mar 18, 2026 | Mar 18 8:30 PM | DANA PIZZUTI | Proposed Sale | 24,756 | $37.89 | $938.0K | — | View → |
| Mar 16, 2026 | Mar 16 1:24 PM | Jeff Knight | Proposed Sale | 25,113 | $37.49 | $941.5K | — | View → |
| Mar 16, 2026 | Mar 16 1:23 PM | Stephen Betz | Proposed Sale | 26,525 | $37.49 | $994.4K | — | View → |
| Mar 16, 2026 | Mar 16 1:23 PM | Richard Scott Struthers | Proposed Sale | 45,013 | $37.49 | $1.7M | — | View → |
| Mar 12, 2026 | Mar 13 9:46 PM | Coelho Rogerio VivaldiDirector | Sale | 5,000 | $36.15 | $180.8K | 16,300(D) | View → |
| Mar 12, 2026 | Mar 12 8:28 PM | ROGERIO VIVALDI COELHO | Proposed Sale | 5,000 | $36.98 | $184.9K | — | View → |
| Mar 3, 2026 | Mar 4 10:44 PM | Stephanie OkeyDirector | Sale | 3,000 | $39.67 | $119.0K | 13,300(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Feb 25 9:37 PM | Struthers Richard ScottDirector, President & CEO | Grant/Award | 228,000 | $43.79 | 228,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:36 PM | Tobin SchilkeChief Financial Officer | Grant/Award | 50,000 | $43.79 | 50,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:34 PM | Jeff E. KnightChief Operating Officer | Grant/Award | 55,000 | $43.79 | 55,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:34 PM | Stephen F. BetzChief Scientific Officer | Grant/Award | 47,000 | $43.79 | 47,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:32 PM | Isabel KalofonosChief Commercial Officer | Grant/Award | 55,000 | $43.79 | 55,000(D) | View → |
← Previous
Page 2 of 2